4.6 Article

Freeze and Thaw of CD4+ CD25+ Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease

期刊

PLOS ONE
卷 10, 期 12, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0145763

关键词

-

资金

  1. SPARK program at Stanford University
  2. Dr. Mildred Scheel Postdoctoral Fellowship from the German Cancer Aid
  3. Stanford Institute for Immunity, Transplantation and Infection
  4. American Society for Blood and Marrow Transplantation
  5. Fondazione Italiana per la Ricerca sul Cancro (FIRC)
  6. Societa Italiana di Ematologia Sperimentale (SIES)
  7. Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL)
  8. New Investigator Award from the American Society for Blood and Marrow Transplantation
  9. Amy Manesevit Award from the National Marrow Donor Program
  10. NIH [5 K08 HL119590]
  11. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom

向作者/读者索取更多资源

The adoptive transfer of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) in murine models of allogeneic hematopoietic cell transplantation (HCT) has been shown to protect recipient mice from lethal acute graft-versus-host disease (GVHD) and this approach is being actively investigated in human clinical trials. Here, we examined the effects of cryopreservation on Tregs. We found that freeze and thaw of murine and human Tregs is associated with reduced expression of L-selectin (CD62L), which was previously established to be an important factor that contributes to the in vivo protective effects of Tregs. Frozen and thawed murine Tregs showed a reduced capacity to bind to the CD62L binding partner MADCAM1 in vitro as well as an impaired homing to secondary lymphoid organs in vivo. Upon adoptive transfer frozen and thawed Tregs failed to protect against lethal GVHD compared with fresh Tregs in a murine model of allogeneic HCT across major histocompatibility barriers. In summary, the direct administration of adoptively transferred frozen and thawed Tregs adversely affects their immunosuppressive potential which is an important factor to consider in the clinical implementation of Treg immunotherapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据